ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $260,000 | -20.0% | 20,867 | -12.1% | 0.00% | 0.0% |
| Q3 2016 | $325,000 | +90.1% | 23,746 | +2.5% | 0.00% | +100.0% |
| Q2 2016 | $171,000 | -10.5% | 23,170 | -22.4% | 0.00% | -50.0% |
| Q1 2016 | $191,000 | -37.6% | 29,848 | -39.0% | 0.00% | -33.3% |
| Q4 2015 | $306,000 | +1.0% | 48,966 | -5.5% | 0.00% | 0.0% |
| Q3 2015 | $303,000 | -29.2% | 51,800 | +0.0% | 0.00% | -25.0% |
| Q2 2015 | $428,000 | +14.7% | 51,784 | +14.4% | 0.00% | 0.0% |
| Q1 2015 | $373,000 | +17.3% | 45,251 | -2.4% | 0.00% | 0.0% |
| Q4 2014 | $318,000 | +42.6% | 46,346 | +12.1% | 0.00% | +33.3% |
| Q3 2014 | $223,000 | +24.6% | 41,341 | +46.7% | 0.00% | 0.0% |
| Q2 2014 | $179,000 | -39.3% | 28,174 | -22.9% | 0.00% | -25.0% |
| Q1 2014 | $295,000 | +143.8% | 36,549 | +106.4% | 0.00% | +100.0% |
| Q4 2013 | $121,000 | – | 17,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
| Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
| Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
| Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
| Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
| Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
| Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
| 1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
| HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |